Gwt-tud Gmbh
Clinical trials sponsored by Gwt-tud Gmbh, explained in plain language.
-
New drug cocktail tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested a combination of three oral medications—pomalidomide, ixazomib, and dexamethasone—for adults with multiple myeloma that has come back or stopped responding to prior treatments. The goal was to see if this drug combo could control the cancer and delay its progres…
Phase: PHASE2 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Two-Pronged attack on tough pancreatic cancer shows promise
Disease control CompletedThis study tested a two-step treatment for advanced pancreatic cancer. First, patients received standard chemotherapy plus experimental drugs designed to make cancer cells more vulnerable. If their disease was controlled after three cycles, they moved to a second phase receiving …
Phase: PHASE1, PHASE2 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC